Johnson & Johnson’s medtech acquisitions over the past year have fueled growth for its cardiovascular group, offsetting ...
Johnson & Johnson beat investors’ expectations despite its medtech unit underperforming, with execs pointing to the Asia-Pacific region as a continued source of struggle. Executives said on the ...
From pulsed field ablation to diabetes tech and surgical robots, the updates will provide an early look at how key medtech ...
JNJ's 3Q earnings expected to be $2.21 EPS and $22.16B revenue. Recent acquisitions and drug trials impacting stock's ...
Employees at the 10 largest medtech employers in the world are excited about culture but are still frustrated by corporate ...
Matt Miksic, an analyst from Barclays, maintained the Hold rating on Johnson & Johnson (JNJ – Research Report). The associated price ...
Focus on international early-stage and pre-commercial biotech & medtech opportunities ...
Event puts focus on medical technologies Oct. 15-17 at the Metro Toronto Convention Centre ...
Authors:Kirk Harmon, Vice President & GM, Contract Sales Organization, IQVIAJavier “Jave” Castillo, R.Ph, Vice President, CSO ...
The Infor Cloverleaf Data Integration Platform is now interoperable with the Nvidia Holoscan AI platform, providing more AI ...
SALT LAKE CITY, UT / ACCESSWIRE / October 14, 2024 / Icovy Marketing, a leading medtech marketing agency, and Chamfr, a marketplace connecting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback